Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1975 Oct;28(10):767–774. doi: 10.1136/jcp.28.10.767

Laboratory tests of antifungal drugs.

R J Holt
PMCID: PMC475856  PMID: 765359

Abstract

The procedures evolved in the author's laboratory over the past 20 years for the microbiological assessment of antifungal drugs are described; methods are detailed for the estimation of the sensitivity of pathogenic fungi to therapeutic agents and for the assay of those agents in body fluids. The preparation and maintenance of stock reference solutions of the drugs, the culture media used, and the incubation temperature and time are discussed. Sensitivity tests by paper disc and by liquid titration for minimal inhibitory and cidal concentrations estimated are described, and the importance of standardized initial inocula is emphasized. Two groups of assay procedures are given, the liquid dilution and the agar diffusion methods, and suitable indicator organisms for both methods are named. The paper concludes with a discussion on the problem of differential assays when two antimycotic agents are in simultaneous clinical use.

Full text

PDF
769

Images in this article

769Image
on p.769
770Image
on p.770
772Image
on p.772
772Image
on p.772

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bindschadler D. D., Bennett J. E. A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis. 1969 Oct;120(4):427–436. doi: 10.1093/infdis/120.4.427. [DOI] [PubMed] [Google Scholar]
  2. HILL G. J., 2nd AMPHOTERICIN B TOXICITY; CHANGES IN RENAL MORPHOLOGY. Ann Intern Med. 1964 Aug;61:349–354. [PubMed] [Google Scholar]
  3. Holt R. J., Newman R. L. Laboratory assessment of the antimycotic drug clotrimazole. J Clin Pathol. 1972 Dec;25(12):1089–1097. doi: 10.1136/jcp.25.12.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holt R. J., Newman R. L. The antimycotic activity of 5-fluorocytosine. J Clin Pathol. 1973 Mar;26(3):167–174. doi: 10.1136/jcp.26.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Holt R. J. Recent developments in antimycotic chemotherapy. Infection. 1974;2(2):95–107. doi: 10.1007/BF01642028. [DOI] [PubMed] [Google Scholar]
  6. LIGHTBOWN J. W., SULITZEANU D. The assay of penicillin in blood-serum using Sarcina lutea. Bull World Health Organ. 1957;17(4-5):553–567. [PMC free article] [PubMed] [Google Scholar]
  7. Marget W., Adam D. Erste Erfahrungen mit dem Breitbandantimykotikum BAY b 5097. Med Klin. 1969 Jul 4;64(27):1235–1238. [PubMed] [Google Scholar]
  8. Plempel M., Bartmann K., Büchel K. H., Regel E. Experimentelle Befunde über ein neues, oral wirksames Antimykotikum mit breiten Wirkungsspektrum. Dtsch Med Wochenschr. 1969 Jun 27;94(26):1356–passim. doi: 10.1055/s-0028-1111223. [DOI] [PubMed] [Google Scholar]
  9. Shadomy S. In vitro studies with 5-fluorocytosine. Appl Microbiol. 1969 Jun;17(6):871–877. doi: 10.1128/am.17.6.871-877.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stewart G. T. Laboratory and Clinical Studies with Nystatin in Post-antibiotic Mycotic Infections. Br Med J. 1956 Mar 24;1(4968):658–660. doi: 10.1136/bmj.1.4968.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Symmers W. S. Amphotericin pharmacophobia. Br Med J. 1973 Nov 24;4(5890):460–463. doi: 10.1136/bmj.4.5890.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wade D., Sudlow G. Fluorometric measurement of 5-fluorocytosine in biological fluids. J Pharm Sci. 1973 May;62(5):828–829. doi: 10.1002/jps.2600620531. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES